Author:
López-Mora Diego Alfonso,Carrió Ignasi,Flotats Albert
Publisher
Springer International Publishing
Reference87 articles.
1. Makrilia N, Syrigou E, Kaklamanos I, Manolopoulos L, Saif MW. Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review. Metal-Based Drugs. 2010;2010:pii:207084.
2. Duggan DB, Petroni GR, Johnson JL, et al. Randomised comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin’s disease: report of an intergroup trial. J Clin Oncol. 2003;21:607–14.
3. Martin WG, Ristow KM, Habermann TM, et al. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin’s lymphoma. J Clin Oncol. 2005;23:7614–20.
4. Sleijfer S. Bleomycin-induced pneumonitis. Chest. 2001;120:617–24.
5. Ginsberg SJ, Comis RL. The pulmonary toxicity of antineoplastic agents. Semin Oncol. 1982;9:34–51.